212 related articles for article (PubMed ID: 38061626)
1. Biomolecular Condensates as Novel Antiviral Targets.
Martin EW; Iserman C; Olety B; Mitrea DM; Klein IA
J Mol Biol; 2024 Feb; 436(4):168380. PubMed ID: 38061626
[TBL] [Abstract][Full Text] [Related]
2. Defining basic rules for hardening influenza A virus liquid condensates.
Etibor TA; Vale-Costa S; Sridharan S; Brás D; Becher I; Mello VH; Ferreira F; Alenquer M; Savitski MM; Amorim MJ
Elife; 2023 Apr; 12():. PubMed ID: 37013374
[TBL] [Abstract][Full Text] [Related]
3. A condensate-hardening drug blocks RSV replication in vivo.
Risso-Ballester J; Galloux M; Cao J; Le Goffic R; Hontonnou F; Jobart-Malfait A; Desquesnes A; Sake SM; Haid S; Du M; Zhang X; Zhang H; Wang Z; Rincheval V; Zhang Y; Pietschmann T; Eléouët JF; Rameix-Welti MA; Altmeyer R
Nature; 2021 Jul; 595(7868):596-599. PubMed ID: 34234347
[TBL] [Abstract][Full Text] [Related]
4. The future of antivirals: broad-spectrum inhibitors.
Debing Y; Neyts J; Delang L
Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332
[TBL] [Abstract][Full Text] [Related]
5. Development of Broad-Spectrum Antiviral Agents-Inspiration from Immunomodulatory Natural Products.
Zhang M; Zhong J; Xiong Y; Song X; Li C; He Z
Viruses; 2021 Jun; 13(7):. PubMed ID: 34203182
[TBL] [Abstract][Full Text] [Related]
6. Intervention strategies for emerging viruses: use of antivirals.
Debing Y; Jochmans D; Neyts J
Curr Opin Virol; 2013 Apr; 3(2):217-24. PubMed ID: 23562753
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation regulates viral biomolecular condensates to promote infectious progeny production.
Grams N; Charman M; Halko E; Lauman R; Garcia BA; Weitzman MD
EMBO J; 2024 Jan; 43(2):277-303. PubMed ID: 38177504
[TBL] [Abstract][Full Text] [Related]
8. Potential Antiviral Action of Alkaloids.
Abookleesh FL; Al-Anzi BS; Ullah A
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164173
[TBL] [Abstract][Full Text] [Related]
9. Antiviral Activity Exerted by Natural Products against Human Viruses.
Musarra-Pizzo M; Pennisi R; Ben-Amor I; Mandalari G; Sciortino MT
Viruses; 2021 May; 13(5):. PubMed ID: 34064347
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of virus replication: recent developments and prospects.
Magden J; Kääriäinen L; Ahola T
Appl Microbiol Biotechnol; 2005 Mar; 66(6):612-21. PubMed ID: 15592828
[TBL] [Abstract][Full Text] [Related]
11. A Broad Antiviral Strategy: Inhibitors of Human DHODH Pave the Way for Host-Targeting Antivirals against Emerging and Re-Emerging Viruses.
Zheng Y; Li S; Song K; Ye J; Li W; Zhong Y; Feng Z; Liang S; Cai Z; Xu K
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632670
[TBL] [Abstract][Full Text] [Related]
12. Rapid Reversible Osmoregulation of Cytoplasmic Biomolecular Condensates of Human Interferon-α-Induced Antiviral MxA GTPase.
Sehgal PB; Yuan H; Jin Y
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361529
[TBL] [Abstract][Full Text] [Related]
13. HSP90: a promising broad-spectrum antiviral drug target.
Wang Y; Jin F; Wang R; Li F; Wu Y; Kitazato K; Wang Y
Arch Virol; 2017 Nov; 162(11):3269-3282. PubMed ID: 28780632
[TBL] [Abstract][Full Text] [Related]
14. Editorial overview: antivirals and resistance: advances and challenges ahead.
Menéndez-Arias L; Richman DD
Curr Opin Virol; 2014 Oct; 8():iv-vii. PubMed ID: 25155454
[No Abstract] [Full Text] [Related]
15. Broad-spectrum antivirals against viral fusion.
Vigant F; Santos NC; Lee B
Nat Rev Microbiol; 2015 Jul; 13(7):426-37. PubMed ID: 26075364
[TBL] [Abstract][Full Text] [Related]
16. Broad-Spectrum Antivirals and Antiviral Drug Combinations.
Oksenych V; Kainov DE
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215894
[TBL] [Abstract][Full Text] [Related]
17. Seeing Biomolecular Condensates Through the Lens of Viruses.
Borodavka A; Acker J
Annu Rev Virol; 2023 Sep; 10(1):163-182. PubMed ID: 37040799
[TBL] [Abstract][Full Text] [Related]
18. Drug Repurposing for Viral Infectious Diseases: How Far Are We?
Mercorelli B; Palù G; Loregian A
Trends Microbiol; 2018 Oct; 26(10):865-876. PubMed ID: 29759926
[TBL] [Abstract][Full Text] [Related]
19. Broad-spectrum antiviral strategy: Host-targeting antivirals against emerging and re-emerging viruses.
He Y; Zhou J; Gao H; Liu C; Zhan P; Liu X
Eur J Med Chem; 2024 Feb; 265():116069. PubMed ID: 38160620
[TBL] [Abstract][Full Text] [Related]
20. Discovery and development of safe-in-man broad-spectrum antiviral agents.
Andersen PI; Ianevski A; Lysvand H; Vitkauskiene A; Oksenych V; Bjørås M; Telling K; Lutsar I; Dumpis U; Irie Y; Tenson T; Kantele A; Kainov DE
Int J Infect Dis; 2020 Apr; 93():268-276. PubMed ID: 32081774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
